Investing in artificial intelligence is easy to get wrong because everything is labeled AI now. The word shows up in filings from industrial conglomerates to restaurant chains. Labels are cheap. Evidence is not. When every company is an AI company, the label means nothing.
The disciplined move is to separate AI revenue from AI rhetoric. Check what the company actually sells, what it spends on R&D, and whether its AI mentions grow alongside real investment or instead of it. Rhetoric is free. R&D shows up in the budget. This takes work, which is exactly why most investors skip it and buy the story instead.
TrueAI does this separation for you across any AI ETF's holdings, scoring each company on mentions, R&D, and genuine signals. A free scorecard covers the top 10 holdings; the full version is $15/mo.
Hype fades. R&D compounds. Put your money on the one that compounds. The investors who do the work get the compounding. The rest get the press releases.
Invest in the spending, not the adjectives.